CTOs on the Move

AAAT.L.C Healthcare

www.aaatlc.com

 
AAAT.L.C Healthcare is a Encino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.aaatlc.com
  • 16055 Ventura Blvd Ste 921
    Encino, CA USA 91436
  • Phone: 818.380.6585

Executives

Name Title Contact Details

Similar Companies

Matrix Medical Network

At Matrix, we understand that access to care often translates to quality of care. In 2007, we broke the mold on the traditional physician office visit care model, and decided that the best place for care is in the home. That`s why we pioneered the use of Nurse Practitioners to visit health plan members where they needed care the most—in their home or a nursing facility.   It is this pioneering attitude that has helped us continue to innovate the way care is delivered. With advanced technology, innovative solutions, highly skilled Nurse Practitioners and exceptional processes, Matrix excels at delivering the right care, at the right place, by the right person…every time. We are changing the way healthcare is delivered.

North American Center for Continuing Medical Education

North American Center for Continuing Medical Education is a Millstone Township, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wingate Living

Senior Living Communities | Wingate Living Step inside Wingate Living and you’ll see that we build more than beautiful residences for older adults. We’re builders of friendships and Senior Living Communities that make you feel right at home. and you’ll...

NEA Medical Center

NEA Medical Center is a Jonesboro, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.